GrowingStockReport.com

NASDAQ Decliners Watch List: Ventrus Biosciences Inc. (NASDAQ:VTUS) and Facebook, Inc. (NASDAQ:FB) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 02/12/2014 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Ventrus Biosciences Inc. (NASDAQ:VTUS) and Facebook, Inc. (NASDAQ:FB).

Ventrus Biosciences Inc. (NASDAQ:VTUS) a development stage specialty pharmaceutical company that focuses on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders is currently down (-61.41%) on 5,815,656 shares traded after Ventrus Biosciences Announced Results From Second Pivotal Phase 3 Trial of Diltiazem Cream in Patients With Anal Fissure. Ventrus Biosciences Inc. (NASDAQ:VTUS) is currently down (-68.66%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Ventrus Biosciences Inc. (NASDAQ:VTUS)

Facebook, Inc. (NASDAQ:FB) operates as a social networking company worldwide is currently down (-0.65%) on 11,066,850 shares traded as Analyst Seriously Discounts Teen Usage Concerns on Facebook. Facebook, Inc. (NASDAQ:FB) is currently down (-0.52%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Facebook, Inc. (NASDAQ:FB)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com